L’avis intitulé « Vaccin antigrippal EFLUELDA : transition du vaccin antigrippal EFLUELDA, de sa forme quadrivalente à une forme trivalente, dans la stratégie de vaccination contre la grippe saisonnière », ci-joint, est adopté.
Voir aussi
Recommandation vaccinale
13/02/2025
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
XGXwkQrreVXpTYut
